Skip to content

Native Tissue Repair in Pelvic Organ Prolapse -Long-term Results and Risk of Re-operation

Native Tissue Repair in Pelvic Organ Prolapse -Long-term Results and Risk of Re-operation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06744972
Enrollment
392
Registered
2024-12-20
Start date
2015-05-31
Completion date
2024-12-31
Last updated
2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystocele, Pelvic Organ Prolapse

Keywords

Recurrence, Native tissue repair

Brief summary

This study evaluates the recurrence of pelvic organ prolapse and the rate of re-operation after primary surgery for anterior vaginal wall prolapse with native tissue repair in long term follow-up.

Detailed description

This was a retrospective cohort study including patients undergoing their first surgical intervention for pelvic organ prolapse in Turku University Hospital gynecology department in the years 2000-2005. The point of interest was to study patients with prolapse of the anterior vaginal compartment (i.e. cystocele) with native tissue repair surgical approach as treatment. We made a search from the medical database of surgical procedures for operation codes LEF00 (i.e.anterior colporraphy and LEF13 (i.e. vaginal hysterectomy of descended uterus with/without vaginal/perineal molding) during the studied period. Initially, we found 699 patients with matching operating codes and for those, we went through their medical records. From the final study population, we excluded those who had previously had an operation for pelvic organ prolapse and those whose primary operation didn't include anterior colporraphy and those who weren't eligible for long term follow-up. Thus, the study population constituted of 392 subjects who were followed through medical records until the end of October 2018. From the medical records, we collected the day of birth, the date of the primary operation, body mass index, history of vaginal childbirth and cesarean section (if available), history of incontinence surgery, the grade of cystocele and diagnosis and before surgery, the operation code and executed surgical procedures, possible complications, and the history of possible re-operations. Also, the date of death was reported as well as the date of changing residence outside the Hospital District of Varsinais-Suomi. All gathered information were saved without personal details.

Interventions

None listed

Sponsors

Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* cystocele treated with native tissue surgery, medical records reaching until the end of follow-up period

Exclusion criteria

* history of previous pelvic organ prolapse surgery

Design outcomes

Primary

MeasureTime frameDescription
Rate of re-operationsLong-term, at least 5 years follow up.Evaluate the risk of re-operation for pelvic organ prolapse and recurrence of surgically treated cystocele.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026